Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a significant amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA), or Worldwide for another indicatio...

Descrición completa

Detalles Bibliográficos
Main Authors: Sergey Shityakov, Ekaterina V. Skorb, Carola Y. Förster, Thomas Dandekar
Formato: Artigo
Idioma:English
Publicado: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Chemistry
Subjects:
scaffold search
approved drugs
drug repurposing
alzheimer's disease
chemical similarity
molecular modeling
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fchem.2021.736509/full

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2021.736509/full

Títulos similares